Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 9 December 2025
Accepted: 13 March 2026
First Online: 28 March 2026
Declarations
:
: H.H.O. has served as a speaker, an advisory board member, and a researcher for AbbVie, Galderma, Janssen, and Novartis. She has also been a clinical investigator for La Roche-Posay, Merck Sharpe and Dohme, Pfizer, and Sanofi; and a speaker and/or an advisory board member for Amgen, Boehringer Ingelheim, Eli Lilly and Takeda. The other authors declare no conflicts of interest.
